Henan Newland Pharmaceutical Co. Ltd. A (301277) — Free Cash Flow Generation Index
Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Free Cash Flow Generation Index of 0.13x as of December 2025. Free cash flow of CN¥15.55 Million represents 0% of operating cash flow (CN¥116.94 Million). See Henan Newland Pharmaceutical Co. Ltd. A short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Henan Newland Pharmaceutical Co. Ltd. A Free Cash Flow Generation Index (2020–2025)
Historical FCF Generation Index trend for Henan Newland Pharmaceutical Co. Ltd. A across 6 annual periods. Explore Henan Newland Pharmaceutical Co. Ltd. A debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Year-by-year Free Cash Flow Generation Index for Henan Newland Pharmaceutical Co. Ltd. A. For the full company profile including market capitalisation, see market cap of Henan Newland Pharmaceutical Co. Ltd. A.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥15.55 Million | CN¥116.94 Million | CN¥101.38 Million | ▲ +5.6% |
| 2024 | 0.13x | CN¥15.97 Million | CN¥126.76 Million | CN¥110.79 Million | ▼ -79.9% |
| 2023 | 0.63x | CN¥162.94 Million | CN¥259.46 Million | CN¥96.51 Million | ▲ +511.9% |
| 2022 | 0.10x | CN¥8.50 Million | CN¥82.85 Million | CN¥74.34 Million | ▼ -78.7% |
| 2021 | 0.48x | CN¥23.68 Million | CN¥49.08 Million | CN¥25.40 Million | ▼ -25.3% |
| 2020 | 0.65x | CN¥30.90 Million | CN¥47.86 Million | CN¥16.96 Million | — |